A recent study evaluates the potential of Nanosota-EB1 and Nanosota-EB2, nanobody inhibitors targeting the Ebola virus.
Middle-aged patients are being struck down according new unconfirmed reports, based on videos shared via Chinese social media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback